Cargando…

Systems Pharmacology Approach and Experiment Evaluation Reveal Multidimensional Treatment Strategy of LiangXueJieDu Formula for Psoriasis

Clinical studies have demonstrated the anti-psoriatic effect of the LiangXueJieDu (LXJD) herbal formula. However, the systemic mechanism and the targets of the LXJD formula have not yet been elucidated. In the present study, a systems pharmacology approach, metabolomics, and experimental evaluation...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jingxia, Wang, Yan, Chen, Weiwen, Fu, Jing, Liu, Yu, Di, Tingting, Qi, Cong, Chen, Zhaoxia, Li, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217833/
https://www.ncbi.nlm.nih.gov/pubmed/34168554
http://dx.doi.org/10.3389/fphar.2021.626267
_version_ 1783710672496885760
author Zhao, Jingxia
Wang, Yan
Chen, Weiwen
Fu, Jing
Liu, Yu
Di, Tingting
Qi, Cong
Chen, Zhaoxia
Li, Ping
author_facet Zhao, Jingxia
Wang, Yan
Chen, Weiwen
Fu, Jing
Liu, Yu
Di, Tingting
Qi, Cong
Chen, Zhaoxia
Li, Ping
author_sort Zhao, Jingxia
collection PubMed
description Clinical studies have demonstrated the anti-psoriatic effect of the LiangXueJieDu (LXJD) herbal formula. However, the systemic mechanism and the targets of the LXJD formula have not yet been elucidated. In the present study, a systems pharmacology approach, metabolomics, and experimental evaluation were employed. First, by systematic absorption-distribution-metabolism-excretion (ADME) analysis, 144 active compounds with satisfactory pharmacokinetic properties were identified from 12 herbs of LXJD formula using the TCMSP database. These active compounds could be linked to 125 target proteins involved in the pathological processes underlying psoriasis. Then, the networks constituting the active compounds, targets, and diseases were constructed to decipher the pharmacological actions of this formula, indicating its curative effects in psoriasis treatment and related complications. The psoriasis-related pathway comprising several regulatory modules demonstrated the synergistic mechanisms of LXJD formula. Furthermore, the therapeutic effect of LXJD formula was validated in a psoriasis-like mouse model. Consistent with the systems pharmacology analysis, LXJD formula ameliorated IMQ-induced psoriasis-like lesions in mice, inhibited keratinocyte proliferation, improved keratinocyte differentiation, and suppressed the infiltration of CD3+ T cells. Compared to the model group, LXJD formula treatment remarkably reduced the expression of inflammatory cytokines and factors, such as IL-1β, IL-6, TNF-α, Cox2, and inhibited the phosphorylation of p-P65, p-IқB, p-ERK, p-P38, p-PI3K, p-AKT, indicating that LXJD formula exerts its therapeutic effect by inhibiting the MAPK, PI3K/AKT, and NF-қB signaling pathways. The metabolic changes in the serum of psoriasis patients were evaluated by liquid chromatography coupled with orbitrap mass spectrometry (LC-MS). The LXJD formula improved two perturbed metabolic pathways of glycerophospholipid metabolism and steroid hormone biosynthesis. Overall, this study revealed the complicated anti-psoriatic mechanism of LXJD formula and also offered a reliable strategy to elucidate the complex therapeutic mechanism of this Chinese herbal formula in psoriasis from a holistic perspective.
format Online
Article
Text
id pubmed-8217833
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82178332021-06-23 Systems Pharmacology Approach and Experiment Evaluation Reveal Multidimensional Treatment Strategy of LiangXueJieDu Formula for Psoriasis Zhao, Jingxia Wang, Yan Chen, Weiwen Fu, Jing Liu, Yu Di, Tingting Qi, Cong Chen, Zhaoxia Li, Ping Front Pharmacol Pharmacology Clinical studies have demonstrated the anti-psoriatic effect of the LiangXueJieDu (LXJD) herbal formula. However, the systemic mechanism and the targets of the LXJD formula have not yet been elucidated. In the present study, a systems pharmacology approach, metabolomics, and experimental evaluation were employed. First, by systematic absorption-distribution-metabolism-excretion (ADME) analysis, 144 active compounds with satisfactory pharmacokinetic properties were identified from 12 herbs of LXJD formula using the TCMSP database. These active compounds could be linked to 125 target proteins involved in the pathological processes underlying psoriasis. Then, the networks constituting the active compounds, targets, and diseases were constructed to decipher the pharmacological actions of this formula, indicating its curative effects in psoriasis treatment and related complications. The psoriasis-related pathway comprising several regulatory modules demonstrated the synergistic mechanisms of LXJD formula. Furthermore, the therapeutic effect of LXJD formula was validated in a psoriasis-like mouse model. Consistent with the systems pharmacology analysis, LXJD formula ameliorated IMQ-induced psoriasis-like lesions in mice, inhibited keratinocyte proliferation, improved keratinocyte differentiation, and suppressed the infiltration of CD3+ T cells. Compared to the model group, LXJD formula treatment remarkably reduced the expression of inflammatory cytokines and factors, such as IL-1β, IL-6, TNF-α, Cox2, and inhibited the phosphorylation of p-P65, p-IқB, p-ERK, p-P38, p-PI3K, p-AKT, indicating that LXJD formula exerts its therapeutic effect by inhibiting the MAPK, PI3K/AKT, and NF-қB signaling pathways. The metabolic changes in the serum of psoriasis patients were evaluated by liquid chromatography coupled with orbitrap mass spectrometry (LC-MS). The LXJD formula improved two perturbed metabolic pathways of glycerophospholipid metabolism and steroid hormone biosynthesis. Overall, this study revealed the complicated anti-psoriatic mechanism of LXJD formula and also offered a reliable strategy to elucidate the complex therapeutic mechanism of this Chinese herbal formula in psoriasis from a holistic perspective. Frontiers Media S.A. 2021-06-08 /pmc/articles/PMC8217833/ /pubmed/34168554 http://dx.doi.org/10.3389/fphar.2021.626267 Text en Copyright © 2021 Zhao, Wang, Chen, Fu, Liu, Di, Qi, Chen and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhao, Jingxia
Wang, Yan
Chen, Weiwen
Fu, Jing
Liu, Yu
Di, Tingting
Qi, Cong
Chen, Zhaoxia
Li, Ping
Systems Pharmacology Approach and Experiment Evaluation Reveal Multidimensional Treatment Strategy of LiangXueJieDu Formula for Psoriasis
title Systems Pharmacology Approach and Experiment Evaluation Reveal Multidimensional Treatment Strategy of LiangXueJieDu Formula for Psoriasis
title_full Systems Pharmacology Approach and Experiment Evaluation Reveal Multidimensional Treatment Strategy of LiangXueJieDu Formula for Psoriasis
title_fullStr Systems Pharmacology Approach and Experiment Evaluation Reveal Multidimensional Treatment Strategy of LiangXueJieDu Formula for Psoriasis
title_full_unstemmed Systems Pharmacology Approach and Experiment Evaluation Reveal Multidimensional Treatment Strategy of LiangXueJieDu Formula for Psoriasis
title_short Systems Pharmacology Approach and Experiment Evaluation Reveal Multidimensional Treatment Strategy of LiangXueJieDu Formula for Psoriasis
title_sort systems pharmacology approach and experiment evaluation reveal multidimensional treatment strategy of liangxuejiedu formula for psoriasis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217833/
https://www.ncbi.nlm.nih.gov/pubmed/34168554
http://dx.doi.org/10.3389/fphar.2021.626267
work_keys_str_mv AT zhaojingxia systemspharmacologyapproachandexperimentevaluationrevealmultidimensionaltreatmentstrategyofliangxuejieduformulaforpsoriasis
AT wangyan systemspharmacologyapproachandexperimentevaluationrevealmultidimensionaltreatmentstrategyofliangxuejieduformulaforpsoriasis
AT chenweiwen systemspharmacologyapproachandexperimentevaluationrevealmultidimensionaltreatmentstrategyofliangxuejieduformulaforpsoriasis
AT fujing systemspharmacologyapproachandexperimentevaluationrevealmultidimensionaltreatmentstrategyofliangxuejieduformulaforpsoriasis
AT liuyu systemspharmacologyapproachandexperimentevaluationrevealmultidimensionaltreatmentstrategyofliangxuejieduformulaforpsoriasis
AT ditingting systemspharmacologyapproachandexperimentevaluationrevealmultidimensionaltreatmentstrategyofliangxuejieduformulaforpsoriasis
AT qicong systemspharmacologyapproachandexperimentevaluationrevealmultidimensionaltreatmentstrategyofliangxuejieduformulaforpsoriasis
AT chenzhaoxia systemspharmacologyapproachandexperimentevaluationrevealmultidimensionaltreatmentstrategyofliangxuejieduformulaforpsoriasis
AT liping systemspharmacologyapproachandexperimentevaluationrevealmultidimensionaltreatmentstrategyofliangxuejieduformulaforpsoriasis